Brief: China Health Group Signs Agreement With Pharmadesk
24/04/2020 24:47
April 24 (Reuters) - China Health Group Inc 8225.HK :
* SIGNS BIOEQUIVALENCE RESEARCH AGREEMENT OF MAIKEXIN ORAL
SOLUTION WITH PHARMADESK
Source text for Eikon: ID:nHKS1TVgr0
Further company coverage: 8225.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on China Health
See all newsBrief: China Health Group Says Court Dismisses Application To Set Aside Arbitration Award
Brief: China Health Says China Medical Group Initiated Legal Proceedings
Brief: China Health Group Says Song Xuemei Tendered Resignation As Executive Director
Brief: China Health Group Says Revenue Recognized In 1Q22 & 2Q22 Has Been Partially Adjusted During 4Q22
Brief: China Health Group Makes Application To Stock Exchange For Resumption In Trading